TD Cowen raised the firm’s price target on Ginkgo Bioworks (DNA) to $16 from $12 and keeps a Buy rating on the shares. The firm said Cell Engineering drove the Q2 beat despite softer biosecurity revenues.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DNA: